Neuphoria Therapeutics (NEUP) Selling, General & Administrative (2023 - 2026)
Neuphoria Therapeutics' Selling, General & Administrative came in at $1.76 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 15.1% from $2.07 million a year earlier but up 4.2% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Selling, General & Administrative (2023 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics' Selling, General & Administrative was $7.44 million, down 4.3% from FY2025.
- Selling, General & Administrative has declined in each of the last three fiscal years, with a three-year compound annual growth rate of -5.8% (FY2023 to FY2026).
- Going back by fiscal year, Selling, General & Administrative was $7.77 million in FY2025 (-8.3%), $8.47 million in FY2024 (-4.9%) and $8.91 million in FY2023.
- The five-year range for quarterly Selling, General & Administrative is $1.2 million (fiscal Q3 2024) to $2.63 million (fiscal Q2 2025).
- Year-over-year, Selling, General & Administrative increased in four of the last eight quarters, with an average decline of 2.9%.
- The fastest year-over-year change in Selling, General & Administrative over five years came in fiscal Q3 2026 (growth of 19.9%), and the weakest in fiscal Q1 2025 (a decline of 29.9%).
- Business Quant data shows NEUP's Selling, General & Administrative at $1.69 million (Q3 2026), $2.13 million (Q2 2026) and $1.87 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Neuphoria Therapeutics | 335.34 Mn | 260.15 Mn | - | 1.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 2.52 Mn |
| Sep 30, 2023 | 2.38 Mn |
API Access
Neuphoria Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();